Mark G MacAskill Selected Research

Diclofenac (SR 38)

8/2015

Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark G MacAskill Research Topics

Disease

2	Infarction (Infarctions) 01/2024 - 01/2021
2	Neuroinflammatory Diseases 01/2024 - 10/2023
2	Thrombosis (Thrombus) 01/2023 - 01/2022
1	Calcinosis 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Vascular Calcification 01/2020
1	Inflammation (Inflammations) 01/2019
1	Ischemia 01/2017
1	Chronic Limb-Threatening Ischemia 01/2017
1	Arteriovenous Fistula 08/2015
1	Hyperplasia 08/2015

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2023
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2024
1	FluoridesIBA 01/2022
1	CalciumIBA 01/2022
1	Platelet Membrane GlycoproteinsIBA 01/2022
1	bis(pyridinio)dichlorocuprate(II)IBA 01/2021
1	Inositol PhosphatesIBA 01/2020
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2020
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020
1	alovudineIBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2015
1	Phenobarbital (Luminal)FDA Link 08/2015
1	Diclofenac (SR 38)FDA LinkGeneric 08/2015

Therapy/Procedure

1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022